WeightCare Semaglutide Review
Join WeightCare, joinweightcare.com
Also spelled as Join WeightCare, joinweightcare.com — Same brand, same great service!
Our investigation of Compounded Semaglutide from WeightCare
$997 for 3 months (~$333/mo); $1,350 3-month high dose; $2,150 6-month high dose; $499 monthly renewal
Investigation Overview
The Pricing Is Published, in Detail
Unusually for this market, WeightCare publishes actual multi-month figures:- Monthly renewal: $499
- 3-month: $997 for 7.5 mg/week over 12 weeks — about $333/month
- 3-month high dose: $1,350 for up to 15 mg/week over 12 weeks — about $450/month
- 6-month high dose: $2,150 for up to 15 mg/week over 24 weeks — about $358/month
Full Refund If You Are Not a Candidate
"If you are deemed a non-candidate for a particular WeightCare treatment by your assigned WeightCare physician, then you will be refunded in full." That is the right policy, and it is not universal. It means a patient who pays and is then declined is not out of pocket for a consultation they could not use.Financing, Disclosed Honestly
WeightCare partners with Affirm for 3-month and 6-month programs, and discloses the terms including the uncomfortable part: "APR options range from 0% to 36%." Publishing a 36% ceiling rather than advertising only the 0% is honest. It also states clearly that "choosing Affirm is a payment option only. It does not affect your clinical eligibility" — separating the credit decision from the medical one.The BMI 20 Problem
WeightCare offers 3-month microdosing plans for semaglutide and tirzepatide "if you're interested in weight management and have a BMI of 20+." A BMI of 20 is squarely within the normal healthy range. The FDA-approved indication begins at 30, or 27 with a weight-related condition. Prescribing a GLP-1 to someone at BMI 20 is not weight management in any clinical sense the approvals contemplate, and microdosing itself has no evidence base — sub-therapeutic doses were not what the trials studied. This is the same pattern we flagged at EllieMD, and the contrast with Setpoint Wellness, which publishes the actual approved thresholds, is stark.Products and Logistics
The catalogue includes semaglutide (all doses), tirzepatide up to 7.5 mg, tirzepatide high doses, a tirzepatide spray, and semaglutide and tirzepatide microdosing. The spray, like other non-injectable formats we have reviewed, has no published absorption or dosing evidence. Prescriptions are filled by what WeightCare calls an "accredited US pharmacy," shipped in a small box with ice packs, arriving in 5-7 business days with tracking. WeightCare's compounding disclosure is correctly worded, noting that compounded drugs are "prepared by a state-licensed sterile compounding pharmacy partner" and "are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review." It also correctly distinguishes Zepbound and Wegovy as FDA-approved for weight loss from Ozempic and Mounjaro as approved for type 2 diabetes and prescribed off-label.State Coverage Is Complicated
Coverage differs by program, which WeightCare publishes rather than hides:- Monthly semaglutide, semaglutide microdose and monthly tirzepatide: all states except AK, HI, LA, MS
- Three-month semaglutide and tirzepatide: all except AK, AR, CA, HI, KY, LA, MS, MT, SC
- Three-month semaglutide microdosing: all except AK, AL, AR, CA, HI, KS, MI, MN, MS
Cancellation Friction
To cancel, WeightCare requires an email to help@joinweightcare.com with "CANCEL" in the subject line, after which an agent confirms. Its FAQ elsewhere points to a patient portal for cancellation steps. Requiring a specifically formatted email rather than a one-click in-account cancellation is friction, and friction in cancellation flows is rarely accidental.Our Investigation Summary
Our research (August 8, 2026) found WeightCare publishing genuinely detailed pricing — $499 monthly renewal, $997 for a 3-month program at 7.5 mg/week (about $333/month), $1,350 for 3-month high dose up to 15 mg/week (about $450/month), and $2,150 for 6-month high dose (about $358/month) — with the per-month arithmetic done for the buyer rather than left obscured. It refunds in full any patient its physician deems a non-candidate, discloses Affirm financing terms including the 0-36% APR range rather than advertising only the headline rate, and states explicitly that choosing financing does not affect clinical eligibility. Its compounding disclosures are correctly worded and it accurately distinguishes FDA-approved indications for Zepbound and Wegovy from off-label use of Ozempic and Mounjaro. State coverage varies by program and is published in full. The significant problem is eligibility: WeightCare offers 3-month microdosing programs to patients with a BMI of 20 or above, which sits squarely inside the normal healthy range and far below the approved threshold of 30, or 27 with a weight-related condition — and microdosing itself uses sub-therapeutic doses that no trial studied. It also sells a tirzepatide spray with no published absorption or dosing evidence. Cancellation requires an email with "CANCEL" in the subject line rather than a one-click in-account option.
How WeightCare Works
Complete a medical questionnaire online
A board-certified physician reviews it and connects with you through the telehealth platform, often same-day
If you are approved, medication ships directly to your door
If your physician deems you a non-candidate, you are refunded in full
Prescriptions are filled by an accredited US pharmacy and shipped with ice packs in a small box
Delivery takes 5-7 business days from prescription, with tracking provided — refrigerate on arrival
Monthly check-ins with physicians plus unlimited messaging are included
Affirm financing is available on 3-month and 6-month programs
What We Found
What's Good
- Publishes real multi-month pricing with the per-month cost calculated for you
- Refunds in full any patient deemed a non-candidate by its physician
- Discloses Affirm financing APRs of 0% to 36% rather than advertising only the best rate
- States clearly that financing does not affect clinical eligibility
- Correctly worded compounding disclosures
- Accurately distinguishes FDA-approved weight-loss indications from off-label diabetes drugs
- Publishes state coverage exclusions by program rather than hiding them
- Board-certified physicians with same-day visits, monthly check-ins and unlimited messaging
- Access to in-house dietitians, fitness trainers and health coaches
- Publishes a phone number as well as an email address
- Temperature-controlled shipping with tracking, 5-7 business days
Watch Out For
- Offers microdosing to patients with a BMI of 20 — inside the normal healthy weight range
- Microdosing uses sub-therapeutic doses that no clinical trial studied
- Sells a tirzepatide spray with no published absorption or dosing evidence
- Cancellation requires an email with 'CANCEL' in the subject line rather than one-click
- Not available in Alaska, Hawaii, Louisiana or Mississippi, with wider exclusions on multi-month plans
- $499 monthly renewal is expensive unless you commit to a multi-month plan
- Compounding pharmacy is described as 'accredited' but is not named, and 503A/503B status is not stated
- Compounded medications are not FDA-approved for safety, effectiveness or quality
Pricing Breakdown
Safety & Medical Oversight
Customer Support
Key Features
Best For
Patients who genuinely meet clinical criteria, want published pricing and a refund guarantee if declined, and will commit to a multi-month plan — but who should avoid the microdosing and spray products
Customer Reviews & Complaints
We assessed WeightCare against its published material as of August 8, 2026.
What we verified directly: pricing of $499 monthly renewal, $997 for 3 months at 7.5 mg/week, $1,350 for 3-month high dose up to 15 mg/week and $2,150 for 6-month high dose; a full refund policy for patients deemed non-candidates; Affirm financing with 0-36% APR disclosed; program-specific state exclusions; shipping from an accredited US pharmacy with ice packs in 5-7 business days; board-certified physician review; and microdosing programs open to BMI 20+.
The pricing transparency deserves credit. WeightCare not only publishes multi-month prices but converts them to monthly equivalents itself — "$997 for 12 weeks, that's like $333/month." Most operators in this category publish nothing, and some publish a headline that obscures the real annual cost.
The BMI 20 microdosing offer is the finding that limits our rating. The FDA-approved indication begins at BMI 30, or 27 with a weight-related condition. Offering GLP-1 treatment at BMI 20 — and at a sub-therapeutic dose no trial evaluated — is a marketing decision, not a clinical one.
Patient comments published by the company describe a 50-pound loss over seven months and note being prescribed anti-nausea medication at the start, which is appropriate practice. They are company-selected.
What we could not establish: the identity of the compounding pharmacy or whether it operates under 503A or 503B, founding year, or independent third-party review aggregates.
Is WeightCare Legit?
"Is WeightCare legitimate?" Our assessment as of August 8, 2026.
Official Verification: WeightCare uses board-certified US-licensed physicians, ships from a US pharmacy with cold-chain packaging and tracking, publishes both a phone number and an email address, and states its state exclusions by program. We found no evidence of wrongdoing.
On commercial conduct it performs well. Published multi-month pricing with monthly equivalents calculated, a full refund for anyone declined by the physician, and financing terms that disclose a 36% APR ceiling instead of advertising only 0% — these are the marks of a company that expects buyers to read the terms. The explicit separation of the credit decision from the clinical decision is a detail many competitors would leave ambiguous.
On clinical gating it does not. Opening microdosing at BMI 20 puts appetite-suppressing medication in front of people at a healthy weight, using doses below anything the trials tested. Set that against Setpoint Wellness, which publishes BMI 27 with a comorbidity or 30+ and holds to it. Both are selling the same drugs; only one is applying the criteria they were approved under.
The cancellation flow is a smaller flag. Requiring a subject line of "CANCEL" and an agent confirmation, rather than a button in your account, adds steps at exactly the moment a customer is trying to leave.
Red Flags Check:
- ✓ Real multi-month pricing published with monthly equivalents
- ✓ Full refund if the physician deems you a non-candidate
- ✓ Financing APR range disclosed, including the 36% ceiling
- ✓ Financing explicitly separated from clinical eligibility
- ✓ Correctly worded compounding and off-label disclosures
- ✓ State exclusions published per program
- ✓ Phone number and email both published
- ⚠ Microdosing offered at BMI 20+, inside the normal weight range
- ⚠ Sub-therapeutic microdosing has no trial evidence
- ⚠ Tirzepatide spray has no absorption or dosing evidence
- ⚠ Cancellation requires a formatted email, not one click
- ⚠ Compounding pharmacy not named; 503A/503B status not stated
The Bottom Line: A company that treats you fairly on money and loosely on medicine. If you clearly meet the clinical criteria and want a standard-dose program with published pricing and a refund if you are declined, WeightCare's terms are among the better ones here. Skip the microdosing plans and the spray — those are products built for a market rather than for a patient. As always, consult your personal physician before starting any new medication program.
Contact Information
Our Verdict: Caution Advised
After our comprehensive investigation, WeightCare receives a 6.6/10 rating. We've identified some concerns that potential customers should be aware of. We recommend reviewing our top picks before proceeding.
Visit WeightCareCoreAge Rx
Our highest-rated GLP-1 weight loss program
WeightCare
$997 for 3 months (~$333/mo); $1,350 3-month high dose; $2,150 6-month high dose; $499 monthly renewal
Investigation Summary
Share Your Experience
Help others by sharing your experience with WeightCare
Want to compare options?
View All 195 ProvidersUser Reviews
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Mochi Health
Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment
Ro
The Brand-Name GLP-1 Route: FDA-Approved Medications Only, with Insurance Concierge Support
More Provider Reviews
CoreAge Rx
Mochi Health
Remedy Meds
Ready to Get Started with WeightCare?
Review our findings above and make an informed decision about WeightCare.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.